This research demonstrates antibacterial efficacy over 99.9% against Escherichia coli and Staphylococcus aureus, indicating a breakthrough in electromagnetic shielding materials.
The increasing prevalence of high-frequency electromagnetic interference (EMI) and bacterial contamination in medical environments demands multifunctional shielding materials that integrate EMI shielding, thermal management, and antimicrobial properties. Herein, an asymmetric trilayer composite film is fabricated via in situ growth of CuS nanoparticles on bacterial cellulose (CuS@BC) and vacuum-assisted assembly with Ti₃C₂Tx MXene and BC/Fe₃O₄ layers. The resulting structure exhibits an exceptional EMI shielding effectiveness of 67.5 dB in the X-band, enabled by a synergistic "reflection-absorption-reabsorption" mechanism. The film also demonstrates dual-mode thermal management, achieving 72.6 °C under Joule heating (at 2.0 V) and 126.6 °C under NIR irradiation (808 nm, 1.0 W/cm²). Furthermore, it shows broad-spectrum antibacterial efficacy exceeding 99.9% against both Staphylococcus aureus and Escherichia coli, without compromising shielding performance. This work provides a new paradigm for flexible multifunctional materials suited to advanced medical electronic applications.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: